INTRODUCTION
Antimicrobial resistance (AMR) is a major public health concern globally and methicillin resistant Staphylococcus aureus (MRSA) is one of the most important pathogens worldwide, accounting for over 80,000 severe infections in the United States alone in 2011 and more than half of hospitalrelated Staphylococcus aureus (S. aureus) infections in most Asian countries. 1, 2 In particular, the spread of MRSA infections from healthcare settings to various community settings over recent decades has raised considerable concern. 3 While the prevalence of methicillin resistance among invasive S. aureus infections is reported to be on the decline in Europe and the US, 4 , 5 resistance remains common in Asia, where self-medication with antibiotics is common. 6 The Asia Pacific region is the most populous region in the world, with one-third of the world's population. 7 With rapid urbanization, a significant proportion of people in this region live in highdensity cities, which increases the risk of the development and spread of antibiotic resistance. 8 Since the 1980's, methicillin resistance detection in S. aureus in healthcare settings within Asia has increased significantly, with regional detection proportions ranging from 26% to 73% in 2011. 9 This poses significant health burden on healthcare systems in the region, especially in resource limited countries where S. aureus infection frequently presents as severe or invasive diseases.
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The overall mortality from S. aureus blood infection was 48% in a study conducted in northeast
Thailand. 11 which is almost double the mortality rate reported in a similar study in the United
States. 12 Although decreasing proportions of healthcare-associated MRSA (HA-MRSA) have been reported in Taiwan and Japan since 2000, community-associated MRSA (CA-MRSA) infections are increasingly detected in the region. 13 As MRSA remains an important cause of nosocomial and community infections in the region, and antibiotic susceptibility patterns may differ between HA-A C C E P T E D M A N U S C R I P T important for the treatment and management of MRSA infections. 14 Besides infections, there have also been increasing reports of MRSA carriage in various population groups in the region, including in young children and adults. 6 While MRSA carriers do not experience clinical symptoms as a result of carriage, they may be at higher risk of MRSA infection especially in the event of hospitalization or major invasive procedures. 15 Nevertheless, epidemiological trends in methicillin-resistance among S. aureus isolates are difficult to determine in the absence of established and standardized common surveillance protocols in the region. 16 Variations in published measures of methicillin-resistance in S. aureus isolates also complicate the interpretability of MRSA detection data. Typically, levels of methicillin resistance in S. aureus within a selected population are measured using isolate-based screening, in which resistance is measured as a proportion of MRSA detected among S. aureus that are successfully isolated from individual samples. This strategy is used by most established AMR surveillance networks, including the European Antimicrobial Resistance Surveillance Network (EARS-Net) and the WHO Global Antimicrobial Resistance Surveillance System (GLASS). 17, 18 However, as more laboratory methods (e.g. screening agars) were made available for the detection of MRSA directly from clinical specimens, some studies today report methicillin resistance levels using a samplebased approach, where resistance is measured as a proportion of MRSA detected from all clinical samples, including samples testing negative for S. aureus. While the isolate-based and the samplebased approaches measure methicillin resistance in S. aureus in different subsets of the population, MRSA resistance quantified with the two approaches is often compared with one another and
described with non-standardized terms such as "resistance", "resistance rates", "incidence" and "prevalence". 19, 20 Therefore, in this systematic review, we sought to document methicillin resistance in S. aureus based on published literature in the Asia Pacific region. We paid particular attention to the surveillance metrics used, and examined the impact of variability in study participants, source of infection, and laboratory methods on MRSA prevalence.
METHODS

Search strategy
This systematic review was conducted in accordance with the PRISMA-P 2015 guidelines. 21 We systematically searched literature published through 5 December 2017 on methicillin resistance in S. aureus reported in 41 countries and regions in the Asia Pacific Region using the bibliographic databases PubMed and Embase (Appendix). Search results were catalogued using bibliographic software (Endnote version X7, Clarivate Analytics), and a database was generated to manage article screening and evaluation. In this review, the Asia Pacific Region refers to countries and regions that comprise Eastern Asia, South-Eastern Asia, and Oceania according to the definitions provided by the United Nations Statistics Division.
Study selection
Three reviewers (WWL, JW and KN) independently screened titles, abstracts, and full texts of articles. Disagreements between the reviewers were resolved by the decision of a fourth author (PW). Studies were included in this review if they were original studies that met all of the following
conditions: (1) assessed methicillin resistance in S. aureus isolated from clinical specimens collected from populations in the Asia Pacific Region, (2) assessed methicillin resistance in S.
aureus isolates between 2000 and 2016, (3) expressed antibiotic resistance in proportions (%) of resistant organisms, (4) were written in English, and (5) had a full text accessible to the review team (Appendix). Studies were excluded if they were (1) randomized controlled trials, reviews, case studies, opinions, or multiple publications of the same dataset (only one publication per dataset was included), (2) studies that did not state laboratory methods or standards for susceptibility testing, (3) studies that did not specify individual drug or antibiotic names used for susceptibility testing, (4) studies that included data before year 2000 that could not be disaggregated from later data, and (5) studies in which the study period was not clearly defined.
The third exclusion criteria was not applicable to studies that assessed methicillin resistance in S.
aureus through automated AST methods or molecular and screening methods such as resistance gene identification with polymerase chain reaction (PCR) and biochemical MRSA screening tests.
Data extraction
We extracted the following data from each included study using a standardized form: author and year of publication, country, type of study, study period, sample population, participant age range, setting, source of infection, sampling site, sample size, laboratory methods, laboratory standards for antimicrobial susceptibility testing, whether unique patient isolates were used to avoid duplication of samples, and proportion of S. aureus resistant to methicillin, cefoxitin, oxacillin, or
flucloxacillin out of total samples tested (prevalence) or S. aureus isolates tested (resistance proportion) (Appendix).
Data analysis
We first described the overall search results (i. isolates from individuals from all ages.
Almost half (45%) of included observations used the disk diffusion method for AST, and oxacillin was used as the test antibiotic in around two-thirds of these observations. Half of all included observations assessed antibiotic resistance of S. aureus isolated from various body sites, and the most common sampling sites were the respiratory tract (22%), blood (14%), and skin or wound (7%). The types of samples collected from the respiratory tract include sputum, nasal swabs, and throat swabs, and samples collected from the skin or wound include pus and swabs taken from sites such as the axilla and groin.
Estimates of MRSA prevalence and resistance proportions
The proportions of MRSA carriage ranged from 0% to 39·1% and 0% to 88·9% respectively. However, these proportions vary considerably between locations (Table 2 ).
Factors that influence prevalence and resistance proportions of MRSA carriage and infections
A high degree of statistical heterogeneity was indicated in estimates of the MRSA prevalence and resistance proportion (prevalence: I 2 = 99.83%, resistance proportion: I 2 = 99.59%) using a restricted maximum-likelihood (REML) random-effects model. Meta-regression analyses were As noted in previous narrative reviews, most studies are hospital-based, single-institution studies conducted predominantly in better-resourced countries in East and Southeast Asia. 6, 13 Although a pooled average MRSA prevalence or resistance proportion could not be reliably estimated for the current review due to the substantial statistical heterogeneity across the included studies, the range of resistance proportions for MRSA infections and prevalence for MRSA carriage recorded in locations where data were available was consistent with previous reports. 6, 9 The range of MRSA infections reported the Asia Pacific region in our study (0% -98.4%) was 34 These factors, along with differences in study settings, AST methods and sampling sites, were often suggested as potential sources of heterogeneity in MRSA detection.
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36 This is consistent with findings from our meta-analysis, where study heterogeneity was found
to account for more than 99% of the variance between study estimates of MRSA prevalence and resistance proportions.
Of all potential contributors to variability in MRSA carriage, estimates at the population level, relatively better-documented ones include age group, 37, 38 and sample population groups based on health and admission status (i.e. inpatient, outpatient, and healthy people). 39 In our study, we found MRSA carriage prevalence higher in adults 65 years or older compared with children below the age of 18 years. While existing literature on the differences in MRSA carriage among different age groups is inconsistent, 40 the higher MRSA carriage prevalence in older adults reported in our study might be the result that most of the studies were conducted in long-term care facilities or nursing homes in the region. [41] [42] [43] [44] This is in contrast with MRSA carriage studies in children or adults, which were often conducted in community settings among healthy participants . We also found MRSA carriage to be lower in outpatients and healthy participants compared with inpatients, which is congruent with the increased likelihood of exposure to resistant organisms in the hospital setting among inpatients.
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For MRSA infections, we did not find statistically significant differences in prevalence or resistance proportions across age groups. Previous studies also suggested an inconsistent pattern in MRSA infections among different age groups, 71 with some studies reporting a higher prevalence of MRSA infections in older adults 72 and others showing the prevalence of MRSA infections higher in children and young adults. 73, 74 Nevertheless, our study suggested that MRSA resistance proportions of MRSA infections varied by source of infections. Consistent with previous studies, resistance proportions for CA-MRSA seem to be lower than HA-MRSA infections, 6 reflecting the
higher proportion of MRSA among S. aureus found in healthcare settings compared with community settings.
As S. aureus most commonly causes skin or soft tissue, respiratory tract, and bloodstream infections. 75 Most studies included in this review reported prevalences and resistance proportions of MRSA infections in isolates sampled from one or more of these sites. We did not find statistically significant differences in prevalences or resistance proportions of MRSA infections in blood, respiratory tract, and skin or wound samples. An important caveat to this finding is that we did not record and consider the type of infection that is associated with the collection of samples for testing (e.g. blood samples collected from patients with respiratory infections are not differentiated from those collected from patients with bacteraemia).
Given the highly circumstantial nature of prevalence and resistance proportions measured by isolate-based and sample-based approaches, it may be useful to consider moving towards surveillance approaches (such as case-based surveillance) in which pathogens and resistance patterns identified through laboratory testing can be explicitly related to patients' clinical conditions or diseases, which may provide data of clinical relevance to guide medical practice, and at the same time reduce data variability within the sample population. The levels of antibiotic resistance measured by isolate-based and sample-based strategies typically contain little information about the proportion of MRSA infections within a specific group of infections, such as skin infections or lower respiratory tract infections such as pneumonia. Studies using isolatebased measurement strategies tend to collect subsequent clinical samples for testing within a where non-prescription use of antimicrobials in China was reported to be 36% compared with Indonesia (17%), India (18%), Vietnam (62%), and Bangladesh (86%).
Our review has a few limitations. First, as our review was limited to data published on international bibliographic databases, the findings derived from our review may lack the insights of unpublished data from health authorities in the Asia Pacific region. However, the reported resistance proportions and prevalence of MRSA in the countries included in our study are generally comparable with data reported to the Global Antimicrobial Resistance Surveillance System.
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Secondly, the inclusion of only published literature written in English also excluded data that were presented in other languages. Although a formal quality assessment was not conducted on included studies, we have incorporated several quality-related exclusion criteria to exclude studies that are likely to be of lower quality. These include the lack of information on laboratory methods and clearly defined study periods.
In conclusion, the resistance proportions and prevalence of MRSA infections in the Asia Pacific is comparable to those reported in other regions. Although there appears to be no significant secular changes in prevalence or resistance proportions of MRSA infections and carriage in the Asia Pacific, our results highlight the greater influence of country income status and the characteristics of the sample population on these measures compared with methodological differences in AST and the need to compare and consider MRSA prevalence and resistance proportions separately as these are two distinct metrics. The total number of articles included in this study differs from the total number of studies (observations) included because some articles include data for more than one country, year, sample population, or study setting. b Resistance proportion is defined as the proportion of methicillin-resistant S. aureus (MRSA) out of the total S. aureus isolates subjected to susceptibility testing for methicillin resistance. c Prevalence is defined as the proportion of MRSA out of the total number of specimens collected or patients recruited in the study. d Antibiotics used for susceptibility testing are not recorded for studies that use automated antibiotic susceptibility testing (AST) methods or genotyping and screening methods such as resistance gene identification with polymerase chain reaction (PCR) and biochemical (chromogenic) MRSA screening tests. 
